Table 3 Clinical outcomes during the course of anticoagulant therapy
Pulmonary embolism | Deep vein thrombosis | Rate ratio (95%CI) | |||
|---|---|---|---|---|---|
N | Events per 100 patient-years | N | Events per 100 patient-years | ||
Patients, N | 14 | 9 | |||
Recurrent PE | 0 | – | 0 | – | – |
Recurrent DVT | 0 | – | 1 | 16.67 (0. 22-92.72) | – |
Major bleeding | 1 | 10.02 (0. 13-55.75) | 1 | 16.67 (0. 22-92.72) | 0.60 (0.04–9.61) |
Site of major bleeding (days) a , | |||||
Epistaxis (32b) | 0 | – | 1 | 16.67 (0. 22-92.72) | – |
GI (534) | 1 | 10.02 (0. 13-55.75) | 0 | – | – |
Non-major bleeding | 3 | 30.06 (6.04–87.83) | 3 | 50 (10.05–146.1) | 0.60 (0. 12-2.98) |
Site of minor bleeding (days) a , | |||||
Epistaxis (9,31,179) | 3 | 30.06 (6.04–87.83) | 0 | – | – |
Others (0b,5,50) | 0 | – | 3 | 50 (10.05–146.1) | – |
Death | 1 | 10.02 (0. 13-55.75) | 0 | – | – |
Causes of death, | |||||
Respiratory insufficiency | 1 | 10.02 (0. 13-55.75) | 0 | – | – |